You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2026

List of Excipients in Branded Drug VICKS ZZZQUIL


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing VICKS ZZZQUIL

Excipient Strategy and Commercial Opportunities for VICKS ZZZQUIL

Last updated: March 5, 2026

What are the key excipient components in VICKS ZZZQUIL?

VICKS ZZZQUIL typically contains active ingredients such as diphenhydramine hydrochloride (25 mg per dose), along with excipients that enhance stability, solubility, and shelf life. The main excipients include:

  • Microcrystalline cellulose: Filler and disintegrant.
  • Seters: Fillers to provide bulk.
  • Flavor agents: To mask bitter taste.
  • Colorants: To maintain product uniformity and aesthetic appeal.
  • Preservatives: Such as sodium benzoate, to prevent microbial growth.
  • Binders and lubricants: As necessary for manufacturing process efficiency.

Excipient choices influence not only product stability and flavor but also consumer perception and regulatory compliance.

How does excipient selection impact formulation performance?

Excipients in ZZZQUIL influence:

  • Bioavailability: Solubility and disintegration depend on excipient properties.
  • Stability and shelf life: Preservatives and antioxidants prevent degradation.
  • Taste masking: Flavor agents reduce bitterness of active ingredients.
  • Manufacturability: Binders and lubricants aid consistent tablet compression.

Selection prioritizes non-reactivity with active ingredients, compatibility with packaging, and compliance with FDA and international regulations.

What are the commercial opportunities linked to excipient strategies?

  1. Creating formulations for non-drowsy variants: Modified excipients can reduce sedative effects, appealing to broader consumer segments.

  2. Ease of manufacturing: Innovations in excipients that enable faster, more cost-effective production can reduce costs and improve margins.

  3. Enhanced product stability: Incorporating advanced preservatives and antioxidants can extend shelf life, reducing returns and waste.

  4. Flavor and formulation customization: Developing proprietary flavor excipients or delivery mechanisms can establish premium variants.

  5. Regulatory differentiation: Using excipients with GRAS (Generally Recognized As Safe) status expedites approval processes.

How is the excipient landscape evolving?

The industry trends show:

  • A shift toward excipients that facilitate "clean label" products.
  • Increased interest in plant-based, non-allergenic excipients to meet consumer health trends.
  • Adoption of excipients enhancing bioavailability, such as lipid-based carriers.
  • Use of multifunctional excipients reducing ingredient count and broadening formulation scope.

Key players like BASF, Dow, and Ashland invest in developing excipients that meet these criteria, expanding market opportunities.

What are the patent and regulatory considerations?

  • Excipient patents are less common but can provide competitive advantages when integrated into proprietary formulations.
  • Regulatory agencies prioritize excipients with established safety profiles; novel excipients require extensive safety data.
  • Post-approval, any formulation change involving excipients must undergo stability testing and regulatory review per FDA and EMA guidelines.

What is the potential for new excipient innovations in ZZZQUIL?

Opportunities include:

  • Sustained-release excipients to support dosage frequency reduction.
  • Taste-masking technologies like nanoparticle encapsulation.
  • Biodegradable, plant-based excipients aligning with consumer clean label demands.
  • Smart excipients responsive to pH or temperature aimed at targeted delivery.

Investment in research and development can differentiate ZZZQUIL in the crowded OTC sleep aid market.

Key Takeaways

  • Excipient selection in ZZZQUIL affects stability, bioavailability, manufacturing, and consumer experience.
  • The trend toward natural, multifunctional, and advanced excipients offers competitive advantages.
  • Opportunities exist in developing formulations with extended shelf life, improved taste, and novel delivery mechanisms.
  • Regulatory pathways favor excipients with established safety profiles, but innovation can provide patent protection and market differentiation.
  • Strategic partnerships with excipient suppliers and ongoing R&D focus can unlock new commercial avenues.

FAQs

1. How do excipients influence ZZZQUIL's shelf life?
Excipients like preservatives and antioxidants prevent microbial growth and chemical degradation, extending shelf life.

2. Can excipient changes affect ZZZQUIL’s regulatory approval?
Yes. Any formulation change involving excipients requires stability testing and regulatory review to ensure compliance.

3. What excipient innovations could reduce production costs?
Excipients that improve compressibility and flow properties could enable faster manufacturing and reduce waste.

4. Are natural excipients viable for OTC sleep aids?
Yes. Consumers increasingly demand natural ingredients, prompting interest in plant-based, hypoallergenic excipients.

5. What are the risks of using novel excipients?
The main risks include regulatory delays, additional safety testing, and potential consumer acceptance issues.


References

  1. U.S. Food and Drug Administration. (2022). Guidance for Industry: Bye-bye to the Old. [FDA guidance document].
  2. Ashland Global Holdings Inc. (2023). Product Portfolio: Excipients. Retrieved from [company website].
  3. BASF. (2022). Innovations in Pharmaceutical Excipients. Retrieved from [company website].
  4. Dow. (2023). Advances in excipient technologies. Retrieved from [company website].
  5. EMA. (2022). Guidelines on Registration of Excipients. European Medicines Agency.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.